Clarus Therapeutics Hldgs Inc (CRXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRXT | ZTS | TAK | NBIX | UTHR |
| Company | Clarus Therapeutics Hldgs Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.0650 | 163.10 | 13.29 | 143.79 | 255.10 |
| High | 0.0749 | 169.99 | 13.30 | 144.09 | 260.34 |
| Low | 0.0475 | 161.38 | 13.21 | 140.12 | 253.93 |
| Last | 0.0475 | 167.93 | 13.28 | 142.36 | 259.52 |
| Change | -0.0215 | +9.43 | +0.09 | -0.67 | +4.38 |
| % Change | -31.16% | +5.95% | +0.70% | -0.47% | +1.72% |
| Volume | 2,737,100 | 3,166,074 | 589,989 | 365,470 | 382,665 |
| 20-Day Average Volume | 4,348,840 | 4,492,834 | 1,626,736 | 768,758 | 523,427 |
| Previous Close | 0.0690 | 158.50 | 13.19 | 143.03 | 255.14 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2088 | 156.57 | 13.31 | 136.87 | 237.73 |
| 20-Day Raw Stochastic | 0.00% | 89.52% | 36.36% | 85.32% | 96.93% |
| 20-Day Relative Strength | 26.48% | 53.24% | 41.75% | 58.50% | 66.52% |
| Weighted Alpha | -96.72 | -11.25 | -20.84 | +48.40 | +24.68 |
| Today's Opinion | 100% Sell | 64% Sell | 100% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 88% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 56% Sell | 80% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -69.75% since 08/29/22 | +9.12% since 04/25/24 | +1.64% since 04/25/24 | +3.81% since 04/25/24 | +9.95% since 04/25/24 |
| Low | 0.0475 on 09/06/22 | 152.63 on 04/26/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.31 on 04/30/24 |
| High | 0.1400 on 08/30/22 | 169.99 on 05/02/24 | 13.30 on 05/02/24 | 145.22 on 05/01/24 | 260.34 on 05/02/24 |
| 1-Month | |||||
| %Chg | -84.34% since 08/05/22 | +1.42% since 04/02/24 | -1.96% since 04/02/24 | +3.82% since 04/02/24 | +13.49% since 04/02/24 |
| Low | 0.0475 on 09/06/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 227.75 on 04/03/24 |
| High | 0.3489 on 08/15/22 | 169.99 on 05/02/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 260.34 on 05/02/24 |
| 3-Month | |||||
| %Chg | -90.08% since 06/06/22 | -11.47% since 02/02/24 | -6.97% since 02/02/24 | +0.89% since 02/02/24 | +21.56% since 02/02/24 |
| Low | 0.0475 on 09/06/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 0.4659 on 06/07/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 260.34 on 05/02/24 |
| 6-Month | |||||
| %Chg | -93.21% since 03/04/22 | +4.00% since 11/02/23 | -4.22% since 11/02/23 | +26.12% since 11/02/23 | +13.69% since 11/02/23 |
| Low | 0.0475 on 09/06/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 3.9400 on 04/20/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 260.34 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,471 | 72,491,408 | 41,744,196 | 14,232,486 | 11,319,541 |
| Shares Outstanding, K | 52,021 | 457,359 | 3,164,837 | 99,507 | 44,366 |
| Annual Sales | 13,960,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -40,620,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 4,050,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -10,690,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 1.96 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/18/22 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.20 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 08/22/22 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.93 | 6.71 | 56.83 | 11.81 |